SER CIK: 1708599

Serina Therapeutics, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY23
millions USD
FY21:
0.13
FY22:
0.02
FY23:
0.10
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−8.04
FY22:
−6.98
FY23:
−6.18
FY24:
−17.0
FY25:
−24.0
(positive)
millions USD
FY21:
–
FY22:
–
FY23:
–
FY24:
−23.6
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
8.70
FY22:
10.5
FY23:
5.27
FY24:
−11.2
FY25:
−19.2
(positive)
Change from FY21 to FY25
millions USD
FY21:
−8.68
FY22:
−10.5
FY23:
5.27
FY24:
−11.1
FY25:
−19.2

All amounts in millions USD Data sources:SEC EDGARTwelve Data